| Recruiting | PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) NCT06967272 | Sinovac Life Sciences Co., Ltd. | Phase 2 |
| Completed | The Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells) NCT06950645 | Sinovac Life Sciences Co., Ltd. | Phase 1 |
| Unknown | The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E NCT05958771 | University of Chile | Phase 3 |
| Active Not Recruiting | Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Todd NCT05621655 | MAXVAX Biotechnology Limited Liability Company | Phase 2 |
| Completed | ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage NCT06882070 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Completed | Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates NCT04185545 | PT Bio Farma | Phase 3 |
| Completed | Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac in Healthy Infants in Vietnam NCT04596696 | Bharat Biotech International Limited | Phase 3 |
| Completed | Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compa NCT03474055 | Serum Institute of India Pvt. Ltd. | Phase 2 / Phase 3 |
| Completed | Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants NCT02728869 | MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Phase 1 / Phase 2 |
| Completed | Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immu NCT02584816 | Serum Institute of India Pvt. Ltd. | Phase 3 |
| Completed | To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavir NCT04819412 | Bharat Biotech International Limited | Phase 3 |
| Completed | Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024) NCT02062385 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Clinical Trial to Study the Effect and Safety of Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis NCT02133690 | Serum Institute of India Pvt. Ltd. | Phase 3 |
| Completed | A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035) NCT01600092 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Enteroadsorbent Polymethylsiloxane vs Probiotic Lactobacillus Reuteri in the Treatment of Rotaviral Gastroente NCT04116307 | University Hospital for Infectious Diseases, Croatia | Phase 4 |
| Completed | Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana NCT01575197 | PATH | Phase 4 |
| Completed | Immunogenicity of Rotavirus Vaccine NCT01199874 | PATH | Phase 4 |
| Completed | Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement NCT01265355 | Christian Medical College, Vellore, India | Phase 2 / Phase 3 |
| Completed | Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in NCT01236066 | GlaxoSmithKline | — |
| Completed | A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan NCT01202201 | GlaxoSmithKline | — |
| Unknown | Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine NCT01061658 | Shantha Biotechnics Limited | Phase 1 / Phase 2 |
| Completed | A Study to Evaluate the Safety of Tetravalent Rotavirus Vaccine in Healthy Indian Adult Male Volunteers NCT01091298 | Shantha Biotechnics Limited | Phase 1 |
| Withdrawn | A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly NCT01003431 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED) NCT00953056 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Epidemiology of Rotavirus Infection in North India Community NCT01508533 | Society for Applied Studies | — |
| Completed | Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island NCT01026779 | Lifespan | — |
| Completed | Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab NCT00737503 | International Centre for Diarrhoeal Disease Research, Bangladesh | Phase 4 |
| Completed | Estimation of the Burden of Rotavirus Gastroenteritis (RV GE) in Children Less Than 5 Years in Greece NCT00751686 | GlaxoSmithKline | — |
| Completed | Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in NCT01177657 | GlaxoSmithKline | — |
| Completed | Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Swed NCT00489567 | GlaxoSmithKline | — |
| Completed | Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective S NCT00740935 | University Hospital, Brest | Phase 4 |
| Completed | Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & NCT00169455 | GlaxoSmithKline | Phase 3 |